Tobacco Abstinence
7
3
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
14%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (7)
Evaluation of Sodium Excretion and Dietary Intake Via a New Sodium Food Frequency Questionnaire
Measuring Communal Coping in Dual-smoking Couples Making a Quit Attempt
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
Varenicline For Smokers In Recovery From Alcohol Dependence
Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study
Effects of Transcranial Direct Current Stimulation on Tobacco Withdrawal Symptoms